Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AREVIA: AV-1959R in Preclinical Alzheimer's Disease
NCT07827768Phase 2Not yet recruiting
- Sponsor
- Institute for Molecular Medicine
- Start
- Oct 2027
- Primary completion
- Oct 2029
01
Overview
A Phase 2 trial of AV-1959R in Alzheimer's disease (AD), sponsored by Institute for Molecular Medicine. Planned start Oct 2027; status: not yet recruiting.
02
Drugs
AV-1959R
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07827768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07827768.